13F-HR filed by Caligan Partners LP
Caligan Partners LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 13 holding rows worth $217,755,783.
- Accession
- 0001727492-23-000011
- Filer
- CIK 1727492
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 13 entries on the cover page, a total value of $217,755,783 stated on the cover page (in dollars after the unit check, H1), rows summing to $217,755,783 with VALUE read as dollars as filed, 13F file number 028-23096. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 9,243,627 | $58,604,595 | dollars as filed | |
| ALIMERA SCIENCES INC | 016259202 | COM | 16,835,154 | $52,188,977 | dollars as filed | |
| INTERCEPT PHARMACEUTICALS IN | 45845P958 | COM | 1,200,000 | $22,248,000 | dollars as filed | put |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 7,622,413 | $22,104,998 | dollars as filed | |
| ANIKA THERAPEUTICS INC | 035255108 | COM | 1,081,360 | $20,145,737 | dollars as filed | |
| EXELIXIS INC COM | 30161Q104 | Stock | 910,730 | $19,899,451 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 1,683,836 | $15,390,261 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 183,064 | $2,983,943 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 597,513 | $2,139,097 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 259,593 | $1,009,817 | dollars as filed | |
| SOCIETAL CDMO INC | 75629F109 | COM | 1,689,768 | $794,191 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 23,321 | $127,099 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 4,833 | $119,617 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001727492-23-000011 | this filing | 2023-11-14 | acceptance time not in the bulk data set |